{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:23:39Z","timestamp":1787318619222,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["20180550997"],"award-info":[{"award-number":["20180550997"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.intimp.2022.109044","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T23:21:13Z","timestamp":1657840873000},"page":"109044","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Effect of Baricitinib on the epithelial-mesenchymal transition of alveolar epithelial cells induced by IL-6"],"prefix":"10.1016","volume":"110","author":[{"given":"Yiping","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanzhi","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanshu","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.intimp.2022.109044_b0005","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/annrheumdis-2020-217230","article-title":"Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs)","volume":"80","author":"Spagnolo","year":"2021","journal-title":"Ann. Rheum. Dis."},{"issue":"Supplement 1","key":"10.1016\/j.intimp.2022.109044_b0010","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1513\/AnnalsATS.201410-448MG","article-title":"Mechanisms of alveolar epithelial injury, repair, and fibrosis","volume":"12","author":"Chambers","year":"2015","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"5","key":"10.1016\/j.intimp.2022.109044_b0015","first-page":"517","article-title":"EMT and interstitial lung disease: a mysterious relationship","volume":"18","author":"Kage","year":"2012","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"5","key":"10.1016\/j.intimp.2022.109044_b0020","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.3390\/ijms22052566","article-title":"The History and Mystery of Alveolar Epithelial Type II Cells: Focus on Their Physiologic and Pathologic Role in Lung","volume":"22","author":"Ruaro","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.intimp.2022.109044_b0025","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3390\/medicina56110608","article-title":"Epithelial-Mesenchymal Transition: A Major Pathogenic Driver in Idiopathic Pulmonary Fibrosis","volume":"56","author":"Salton","year":"2020","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"10.1016\/j.intimp.2022.109044_b0030","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.smim.2014.01.008","article-title":"The two faces of IL-6 in the tumor microenvironment","volume":"26","author":"Fisher","year":"2014","journal-title":"Semin. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109044_b0035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cyto.2014.05.024","article-title":"Interleukin-6 and its receptors: a highly regulated and dynamic system","volume":"70","author":"Wolf","year":"2014","journal-title":"Cytokine"},{"issue":"8","key":"10.1016\/j.intimp.2022.109044_b0040","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1182\/blood-2004-12-4602","article-title":"Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease","volume":"106","author":"Nishimoto","year":"2005","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.intimp.2022.109044_b0045","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1038\/sj.onc.1209281","article-title":"Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production","volume":"25","author":"Ogata","year":"2006","journal-title":"Oncogene"},{"issue":"8-9","key":"10.1016\/j.intimp.2022.109044_b0050","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1016\/j.molimm.2009.02.018","article-title":"STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria","volume":"46","author":"Samavati","year":"2009","journal-title":"Mol. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2022.109044_b0055","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/jid.2008.337","article-title":"Cytokine profiling and Stat3 phosphorylation in epithelial-mesenchymal interactions between keloid keratinocytes and fibroblasts","volume":"129","author":"Lim","year":"2009","journal-title":"J. Invest. Dermatol."},{"issue":"12","key":"10.1016\/j.intimp.2022.109044_b0060","doi-asserted-by":"crossref","first-page":"6211","DOI":"10.3390\/ijms22126211","article-title":"Role of JAK\/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms","volume":"22","author":"Montero","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2022.109044_b0065","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s40265-017-0723-3","article-title":"Baricitinib: First Global Approval","volume":"77","author":"Markham","year":"2017","journal-title":"Drugs"},{"issue":"8","key":"10.1016\/j.intimp.2022.109044_b0070","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.nmd.2018.05.007","article-title":"229th ENMC international workshop: Limb girdle muscular dystrophies - Nomenclature and reformed classification Naarden, the Netherlands, 17\u201319 March 2017","volume":"28","author":"Straub","year":"2018","journal-title":"Neuromuscul. Disord."},{"issue":"1","key":"10.1016\/j.intimp.2022.109044_b0075","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1590\/S1806-37132011000100015","article-title":"Myositis-related interstitial lung disease and antisynthetase syndrome","volume":"37","author":"Solomon","year":"2011","journal-title":"J. Bras. Pneumol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109044_b0080","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.nmd.2019.10.005","article-title":"239th ENMC International Workshop: Classification of dermatomyositis, Amsterdam, the Netherlands, 14\u201316 December 2018","volume":"30","author":"Mammen","year":"2020","journal-title":"Neuromuscul. Disord."},{"issue":"5","key":"10.1016\/j.intimp.2022.109044_b0085","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.intimp.2022.109044_b0090","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s00408-020-00383-w","article-title":"Connective Tissue Disease-Related Interstitial Lung Disease: Prevalence, Patterns, Predictors, Prognosis, and Treatment","volume":"198","author":"Jeganathan","year":"2020","journal-title":"Lung"},{"issue":"4","key":"10.1016\/j.intimp.2022.109044_b0095","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3904\/kjim.2016.212","article-title":"Treatment of connective tissue disease-associated interstitial lung disease: the pulmonologist\u2019s point of view","volume":"32","author":"Koo","year":"2017","journal-title":"Korean J. Intern. Med."},{"issue":"9","key":"10.1016\/j.intimp.2022.109044_b0100","first-page":"1472","article-title":"Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Prospective Cohort Study","volume":"71","author":"Sparks","year":"2019","journal-title":"ArthritisRheumatol"},{"issue":"7","key":"10.1016\/j.intimp.2022.109044_b0105","first-page":"8391","article-title":"Cytokine expression in patients with interstitial lung disease in primary Sjogren\u2019s syndrome and its clinical significance","volume":"13","author":"Yang","year":"2021","journal-title":"Am. J. Transl. Res."},{"issue":"Pt 19","key":"10.1016\/j.intimp.2022.109044_b0110","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1242\/jcs.099697","article-title":"Early events in cell adhesion and polarity during epithelial-mesenchymal transition","volume":"125","author":"Huang","year":"2012","journal-title":"J. Cell Sci."},{"issue":"5\u20136","key":"10.1016\/j.intimp.2022.109044_b0115","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/1759720X18776224","article-title":"The role of the JAK\/STAT signal pathway in rheumatoid arthritis","volume":"10","author":"Malemud","year":"2018","journal-title":"Ther. Adv. Musculoskelet Dis."},{"key":"10.1016\/j.intimp.2022.109044_b0120","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.clim.2016.09.014","article-title":"Role of the JAK\/STAT signaling pathway in regulation of innate immunity in neuroinflammatory diseases","volume":"189","author":"Yan","year":"2018","journal-title":"Clin. Immunol."},{"issue":"42","key":"10.1016\/j.intimp.2022.109044_b0125","doi-asserted-by":"crossref","first-page":"30708","DOI":"10.1074\/jbc.M113.478685","article-title":"Transforming growth factor-\u03b2 (TGF-\u03b2)-mediated connective tissue growth factor (CTGF) expression in hepatic stellate cells requires Stat3 signaling activation","volume":"288","author":"Liu","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.intimp.2022.109044_b0130","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-020-2133-2","article-title":"Resolvin D1 suppresses pannus formation via decreasing connective tissue growth factor caused by upregulation of miRNA-146a-5p in rheumatoid arthritis","volume":"22","author":"Sun","year":"2020","journal-title":"Arthritis Res. Ther."},{"issue":"9","key":"10.1016\/j.intimp.2022.109044_b0135","doi-asserted-by":"crossref","first-page":"e45430","DOI":"10.1371\/journal.pone.0045430","article-title":"IFN-\u03b3 and TNF-\u03b1 synergize to inhibit CTGF expression in human lung endothelial cells","volume":"7","author":"Laug","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.intimp.2022.109044_b0140","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3892\/ijmm.2020.4592","article-title":"The JAK2\/STAT3 pathway inhibitor, AG490, suppresses the abnormal behavior of keloid fibroblasts in vitro","volume":"46","author":"Zhou","year":"2020","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.intimp.2022.109044_b0145","doi-asserted-by":"crossref","first-page":"7237","DOI":"10.2147\/IJN.S209458","article-title":"Repeated intravenous administration of silica nanoparticles induces pulmonary inflammation and collagen accumulation via JAK2\/STAT3 and TGF-\u03b2\/Smad3 pathways in vivo","volume":"14","author":"Yu","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.intimp.2022.109044_b0150","doi-asserted-by":"crossref","first-page":"106748","DOI":"10.1016\/j.intimp.2020.106748","article-title":"Efficacy of baricitinib in treating rheumatoid arthritis: Modulatory effects on fibrotic and inflammatory biomarkers in a real-life setting","volume":"86","author":"d'Alessandro","year":"2020","journal-title":"Int. Immunopharmacol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922005288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922005288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:51:39Z","timestamp":1761587499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922005288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":30,"alternative-id":["S1567576922005288"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109044","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Baricitinib on the epithelial-mesenchymal transition of alveolar epithelial cells induced by IL-6","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109044"}}